Novo Nordisk missed its diversity targets last year, and its CEO paid a financial price
7
1
05.02.2025
Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI targets.
© Fortune
visit website